Schering-Plough sees cholesterol drug sales rising
692853
Schering-Plough Corp  said on Thursday that it expects to report higher sales of its cholesterol drugs Vytorin and Zetia in the fourth quarter of 2007 and in 2008 even though they face growing competition.
672686
Germany&#39;s Bayer AG has entered into a strategic pharmaceuticals alliance with Schering-Plough, Bayer said Monday. It said Schering-Plough would market and distribute some Bayer
340592
MUNICH - The statin war is hotting up, and the annual meeting of the European Association for the Study of Diabetes in Munich this week is the latest battleground for these cholesterol-lowering drugs.
411592
It makes sense for the drugmaker to sell millions more shares right now.
365339
Pfizer Inc. , the world's biggest drugmaker, on Wednesday said third-quarter earnings rose on higher sales of key medicines.
218452
The drug maker said net income rose 6 percent to $926.3 million and it raised its outlook for the year.
398157
An experimental cholesterol treatment touted by drugmaker Merck &amp; Co. significantly reduced artery-clogging fats in late-stage testing, but it got a mixed reception from Wall Street analysts Tuesday.
594500
Schering-Plough Corp. SGP.N on  Thursday reported a quarterly profit after a year-ago loss, as  positive foreign exchange trends helped offset poor sales of  its allergy and hepatitis drugs.
455038
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol drug Vytorin after a study showed it was no better than a generic in preventing the build-up of fatty plaque.
310098
Schering-Plough Corp.  on Monday said quarterly earnings more than doubled on growing demand for its Zetia and Vytorin cholesterol drugs and its treatments for arthritis and allergies.
620499
Sales of its lead drug should expand in 2008.
590148
Schering-Plough Corp. SGP.N is   seriously considering approaching Bristol-Myers Squibb Co.   BMY.N about a possible merger, according to a report in The   Star-Ledger newspaper on Friday.
575614
Merck and Schering report bad news, but how much will it affect sales?
453864
Use of cholesterol and blood pressure medicines by young adults appears to be rising rapidly Â at a faster pace than among senior citizens, according to an industry report being released Tuesday.
280625
U.S. regulators said on Friday they would review whether to take action over Merck & Co Inc's and Schering-Plough Corp's popular cholesterol medicine Vytorin after a study showed it was no better than a generic drug in preventing the build-up of fatty plaque.
750251
BOSTON (CBS.MW) -- Pharmaceutical conglomerates Schering-Plough and Bayer have entered into a broad joint-marketing deal Monday for several of the companies&#39; leading drugs.
144217
U.S. prescription drug sales rose 8.3 percent to $274.9 billion last year, fueled by the Medicare drug benefit, increased use of generic medicines and new treatments for diseases such as cancer and diabetes, according to a new report.